Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional study

BackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) in lean individuals indicates metabolic dysfunction and elevates risks of metabolic and cardiovascular diseases. Thus far, no studies have specifically examined the prevalence and risk factors of MAFLD in lean individuals with bi...

Full description

Saved in:
Bibliographic Details
Main Authors: Weihong Lei, Jiahuan Li, Yiyi Liu, Ying Wang, Qing Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1605484/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839609367076274176
author Weihong Lei
Weihong Lei
Weihong Lei
Jiahuan Li
Jiahuan Li
Jiahuan Li
Yiyi Liu
Yiyi Liu
Yiyi Liu
Ying Wang
Ying Wang
Qing Wu
Qing Wu
Qing Wu
author_facet Weihong Lei
Weihong Lei
Weihong Lei
Jiahuan Li
Jiahuan Li
Jiahuan Li
Yiyi Liu
Yiyi Liu
Yiyi Liu
Ying Wang
Ying Wang
Qing Wu
Qing Wu
Qing Wu
author_sort Weihong Lei
collection DOAJ
description BackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) in lean individuals indicates metabolic dysfunction and elevates risks of metabolic and cardiovascular diseases. Thus far, no studies have specifically examined the prevalence and risk factors of MAFLD in lean individuals with bipolar disorder.MethodsThis retrospective study included 1,072 patients aged 18 to 60 years. Participants were classified into two groups based on their Body Mass Index (BMI): those with a BMI ≥24 kg/m² were categorized as overweight or obese, while those with a BMI <24 kg/m² were defined as lean. Data were extracted from inpatient records at the Anhui Mental Health Center.ResultsMAFLD prevalence markedly differed between groups (lean: 10.5% vs. overweight/obese: 76.3%, p<0.001). Among lean BD patients, MAFLD-positive and MAFLD-negative subgroups significantly differed in: age, onset age, illness duration, BMI, ALT, key metabolic indices, marital status, diabetes, and hypertension. Stepwise binary logistic regression analysis revealed that fasting blood glucose level, triglyceride level, gamma-glutamyl transferase (GGT) level, female gender and diabetes status were significant risk factors for MAFLD, while high-density lipoprotein (HDL) level was identified as a protective factor.ConclusionMAFLD is clinically relevant in lean BD patients. Fasting blood glucose level, triglyceride level, GGT level, female gender, and diabetes status were significant risk factors for MAFLD, whereas HDL level was a significant protective factor. Given the potential harm of MAFLD, it is essential to enhance vigilance and underscore the necessity of monitoring MAFLD among individuals with bipolar disorder, especially those who are lean.
format Article
id doaj-art-ab9ef3f1054b443f9ca376f4f50ca85a
institution Matheson Library
issn 1664-2392
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-ab9ef3f1054b443f9ca376f4f50ca85a2025-07-30T09:53:15ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-07-011610.3389/fendo.2025.16054841605484Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional studyWeihong Lei0Weihong Lei1Weihong Lei2Jiahuan Li3Jiahuan Li4Jiahuan Li5Yiyi Liu6Yiyi Liu7Yiyi Liu8Ying Wang9Ying Wang10Qing Wu11Qing Wu12Qing Wu13School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, ChinaDepartment of Psychiatry, Affiliated Psychological Hospital of Anhui Medical University, Hefei, ChinaAnhui Mental Health Center, Hefei Fourth People’s Hospital, Hefei, ChinaSchool of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, ChinaDepartment of Psychiatry, Affiliated Psychological Hospital of Anhui Medical University, Hefei, ChinaAnhui Mental Health Center, Hefei Fourth People’s Hospital, Hefei, ChinaSchool of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, ChinaDepartment of Psychiatry, Affiliated Psychological Hospital of Anhui Medical University, Hefei, ChinaAnhui Mental Health Center, Hefei Fourth People’s Hospital, Hefei, ChinaDepartment of Psychiatry, Affiliated Psychological Hospital of Anhui Medical University, Hefei, ChinaAnhui Mental Health Center, Hefei Fourth People’s Hospital, Hefei, ChinaSchool of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, ChinaDepartment of Psychiatry, Affiliated Psychological Hospital of Anhui Medical University, Hefei, ChinaAnhui Mental Health Center, Hefei Fourth People’s Hospital, Hefei, ChinaBackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) in lean individuals indicates metabolic dysfunction and elevates risks of metabolic and cardiovascular diseases. Thus far, no studies have specifically examined the prevalence and risk factors of MAFLD in lean individuals with bipolar disorder.MethodsThis retrospective study included 1,072 patients aged 18 to 60 years. Participants were classified into two groups based on their Body Mass Index (BMI): those with a BMI ≥24 kg/m² were categorized as overweight or obese, while those with a BMI <24 kg/m² were defined as lean. Data were extracted from inpatient records at the Anhui Mental Health Center.ResultsMAFLD prevalence markedly differed between groups (lean: 10.5% vs. overweight/obese: 76.3%, p<0.001). Among lean BD patients, MAFLD-positive and MAFLD-negative subgroups significantly differed in: age, onset age, illness duration, BMI, ALT, key metabolic indices, marital status, diabetes, and hypertension. Stepwise binary logistic regression analysis revealed that fasting blood glucose level, triglyceride level, gamma-glutamyl transferase (GGT) level, female gender and diabetes status were significant risk factors for MAFLD, while high-density lipoprotein (HDL) level was identified as a protective factor.ConclusionMAFLD is clinically relevant in lean BD patients. Fasting blood glucose level, triglyceride level, GGT level, female gender, and diabetes status were significant risk factors for MAFLD, whereas HDL level was a significant protective factor. Given the potential harm of MAFLD, it is essential to enhance vigilance and underscore the necessity of monitoring MAFLD among individuals with bipolar disorder, especially those who are lean.https://www.frontiersin.org/articles/10.3389/fendo.2025.1605484/fullbipolar disorderMAFLDlean typeprevalencerisk factors
spellingShingle Weihong Lei
Weihong Lei
Weihong Lei
Jiahuan Li
Jiahuan Li
Jiahuan Li
Yiyi Liu
Yiyi Liu
Yiyi Liu
Ying Wang
Ying Wang
Qing Wu
Qing Wu
Qing Wu
Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional study
Frontiers in Endocrinology
bipolar disorder
MAFLD
lean type
prevalence
risk factors
title Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional study
title_full Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional study
title_fullStr Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional study
title_full_unstemmed Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional study
title_short Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional study
title_sort prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder a retrospective cross sectional study
topic bipolar disorder
MAFLD
lean type
prevalence
risk factors
url https://www.frontiersin.org/articles/10.3389/fendo.2025.1605484/full
work_keys_str_mv AT weihonglei prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT weihonglei prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT weihonglei prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT jiahuanli prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT jiahuanli prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT jiahuanli prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT yiyiliu prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT yiyiliu prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT yiyiliu prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT yingwang prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT yingwang prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT qingwu prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT qingwu prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy
AT qingwu prevalenceandriskfactorsofmetabolicassociatedfattyliverdiseaseinleanpatientswithbipolardisorderaretrospectivecrosssectionalstudy